-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RhMEMAlRoUOO1WNo0wlhv9hdiw+LSUj7xPZWaTOYPsWOTNe220e+j0AkcccARLcj UqxJs8/SQmJxN4Wb17IRCw== 0001181431-10-004330.txt : 20100122 0001181431-10-004330.hdr.sgml : 20100122 20100122170610 ACCESSION NUMBER: 0001181431-10-004330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100121 FILED AS OF DATE: 20100122 DATE AS OF CHANGE: 20100122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boissonneault Roger M CENTRAL INDEX KEY: 0001374278 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53772 FILM NUMBER: 10542646 MAIL ADDRESS: STREET 1: C/O WARNER CHILCOTT HOLDINGS CO., LTD. STREET 2: 100 ENTERPRISE DRIVE CITY: ROCKAWAY STATE: NJ ZIP: 07866 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Warner Chilcott plc CENTRAL INDEX KEY: 0001323854 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980496358 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UNIT 19 ARDEE BUSINESS PARK STREET 2: HALE STREET CITY: ARDEE, CO. LOUTH, IRELAND STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 41 685 6983 MAIL ADDRESS: STREET 1: UNIT 19 ARDEE BUSINESS PARK STREET 2: HALE STREET CITY: ARDEE, CO. LOUTH, IRELAND STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Warner Chilcott Ltd DATE OF NAME CHANGE: 20060914 FORMER COMPANY: FORMER CONFORMED NAME: Warner Chilcott Holdings Co Ltd DATE OF NAME CHANGE: 20050414 4 1 rrd263603.xml X0303 4 2010-01-21 0 0001323854 Warner Chilcott plc WCRX 0001374278 Boissonneault Roger M C/O WARNER CHILCOTT CORPORATION 100 ENTERPRISE DRIVE ROCKAWAY NJ 07866 1 1 0 0 CEO & President Ordinary shares, par value $0.01 per share 2010-01-21 4 S 0 13658 28.1724 D 1934050 D Ordinary shares, par value $0.01 per share 300000 I See Footnote The reported securities were sold pursuant to an existing 10b5-1 plan to cover taxes associated with the vesting of restricted shares. The reported securities are held by a trust for the benefit of children of the reporting person. /s/ Roger M. Boissonneault 2010-01-22 -----END PRIVACY-ENHANCED MESSAGE-----